|Articles|September 7, 2022
- Applied Clinical Trials-09-01-2022
- Volume 31
- Issue 9
Applied Clinical Trials September 2022 Issue (PDF)
Advertisement
Articles in this issue
almost 4 years ago
The Powerful Impact of Caregivers on Clinical Trialsalmost 4 years ago
Clinical Research Needs Greater Participant Diversityalmost 4 years ago
The Eradication of False Signals in Monitoringalmost 4 years ago
‘Record’ Gains in Bringing Research Closer to the Patientalmost 4 years ago
Contemplating a Pressing Drug Development Paradoxalmost 4 years ago
Evaluating the Use of Backup Solutions for ePRO Systemsalmost 4 years ago
Filling the Gaps in Clinical Trial Education, Literacyalmost 4 years ago
CRAACO, Moving Trials Closer to Patientsalmost 4 years ago
Getting Up to Speed on EU’s New Trial Application Systemalmost 4 years ago
Top Priority for Califf is Combating Health MisinformationAdvertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Pauses Real-Time Release of Drug Rejection Letters While Working to Formalize Policy
2
ACT Brief: FDA CRL Transparency Pause, Protocol-Centric Recruitment Model Shift, and Medical Affairs Integration in Development
3
ACT Brief: Single Pivotal Trial Stakes, Configurable FSP Strategy, and G-CSF Biosimilar Portfolio Expansion
4
Bringing the Voice of Clinical Practice and Patients into Drug Development
5